Symptom → Plant Sources
Arnica (Arnica montana) as a tool for helping with Arthritis / joint pain
inferred from anti-inflammatory action
← Back to Symptom-to-Plant Lookup
Full Arnica monograph →All plants for arthritis / joint pain →
Background: Homeopathic Arnica montana is used in surgery as prevention or treatment for the reduction of pain and other sequelae of surgery. Our aim was to perform a metaanalysis of clinical trials to assess efficacy of Arnica montana to reduce the inflammatory response after surgery. Method: We conducted a systematic review and metaanalysis, following a predefined protocol, of all studies on the use of homeopathic Arnica montana in surgery. We included all randomized and nonrandomized studies comparing homeopathic Arnica to a placebo or to another active comparator and calculated two quantitative metaanalyses and appropriate sensitivity analyses. We used "Hegde's g," an effect size estimator which is equivalent to a standardized mean difference corrected for small sample bias. The PROSPERO registration number is CRD42020131300. Results: Twenty-three publications reported on 29 different comparisons. One study had to be excluded because no data could be extracted, leaving 28 comparisons. Eighteen comparisons used placebo, nine comparisons an active control, and in one case Arnica was compared to no treatment. The metaanalysis of the placebo-controlled trials yielded an overall effect size of Hedge's g = 0.18 (95% confidence interval -0.007/0.373; p = 0.059). Active comparator trials yielded a highly heterogeneous significant effect size of g = 0.26. This is mainly due to the large effect size of nonrandomized studies, which converges against zero in the randomized trials. Conclusion: Homeopathic Arnica has a small effect size over and against placebo in preventing excessive hematoma and other sequelae of surgeries. The effect is comparable to that of anti-inflammatory substances.
Objectives Arnica montana is a widely used therapeutic plant used traditionally to treat various ailments. The objective of this study was to evaluate the botany, phytochemistry and ethnopharmacology along with special emphasis given on pharmacological activity of plant A. montana. Key findings The plant extracts have been reported to possess antibacterial, antitumor, antioxidant, anti-inflammatory, antifungal and immunomodulatory activity. A wide range of chemical compounds including sesquiterpene lactones and their short-chain carbonic acid esters, flavonoids, carotenoids, essential oils, diterpenes, arnidiol, pyrrolizidine alkaloids, coumarins, phenolic acids, lignans and oligosaccharides, etc., are found in different parts of the plant. Summary It has been scrutinized that extensive research has been carried out to explore the therapeutic potential of flowers of the plant. Therefore, investigations should be carried out to explore the therapeutic potential of other parts of the plant for better therapeutic utilization.
2 sources supporting Arnica for Arthritis / joint pain. Includes scientific publications, books, monographs and traditional-use references.
Mechanistic basis
This use is associated with the plant's anti-inflammatory action. Further evidence for that pharmacology:
Arnica montana L. has a long tradition in Europe as herbal medicine; Arnica flowers are monographed in the European Pharmacopoeia and a EU herbal monograph recommends topical use to treat blunt injuries and traumas, inflammations and rheumatic muscle and joint complaints. The main bioactive constituents are sesquiterpene lactones of the helenanolide type (esters of helenalin and 11alpha,13-dihydrohelenalin), which are the main active principles responsible for the drug's anti-inflammatory efficacy. The review summarizes botanical, phytochemical and pharmacological evidence, including chemotype differences by geographic origin.
This review of Arnica montana in post-surgical settings, pain management and inflammatory conditions overviews its therapeutic use and mechanisms of action, supporting the analgesic and anti-inflammatory use of arnica.
Arnica montana mother tincture and dilutions reduced inflammatory markers in several cell models, helping to clarify the anti-inflammatory mechanism behind the traditional use of arnica for trauma and swelling.
Arnica montana whole-plant (planta tota) and flower (flos) extracts both inhibited inflammation in vitro and in a mouse paw-oedema model, supporting the anti-inflammatory use of arnica.
Topical Arnica montana reduced inflammation and tissue damage in a UVB-induced skin-burn model in mice, supporting the anti-inflammatory and healing use of arnica on the skin.
A polymeric polysaccharide complex isolated from the flowering parts of Arnica montana was characterised and showed immunomodulatory and anti-inflammatory pharmacodynamic properties, documenting bioactive constituents of arnica.